— Know what they know.
Not Investment Advice

IVVD NASDAQ

Invivyd, Inc.
1W: -10.9% 1M: +3.5% 3M: -0.2% YTD: -66.7% 1Y: -31.8% 3Y: -53.5% 5Y: -98.1%
$0.82
+0.01 (+0.69%)
 
Weekly Expected Move ±21.5%
$0 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $242.2M mcap · 250M float · 2.01% daily turnover · Short 61% of daily vol

Cash Flow Trends

Operating Cash Flow
-$58M +65.9% ▲
Capital Expenditures
$155K -10.7% ▼
Free Cash Flow
-$58M +65.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$157M +219.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$227M-$241M-$199M-$170M-$52M
Depreciation & Amort.$1K$462K$2M$3M$2M
Stock-Based Comp.$18M$22M$19M$20M$12M
Change in Working Capital$23M-$16M$6M-$23M-$20M
Other Non-Cash Items$1M$15M-$1M$0$298K
Operating Cash Flow-$185M-$220M-$173M-$170M-$58M
— Investing Activities —
Capital Expenditures-$84K-$2M-$615K-$140K-$155K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$189M-$298M-$91M$0$0
Investment Sales$138M$69M$373M$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$51M-$231M$281M-$140K-$155K
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0-$4K-$1K$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$3M$510K$1M$46K$0
Financing Cash Flow$663M$506K$1M$39M$216M
Net Change in Cash$427M-$450M$109M-$131M$157M
Cash End of Period$542M$92M$201M$69M$227M
Free Cash Flow-$185M-$222M-$174M-$171M-$58M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms